185 related articles for article (PubMed ID: 24267969)
1. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design.
Dholakia AS; Kumar R; Raman SP; Moore JA; Ellsworth S; McNutt T; Laheru DA; Jaffee E; Cameron JL; Tran PT; Hobbs RF; Wolfgang CL; Herman JM
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1007-15. PubMed ID: 24267969
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
[TBL] [Abstract][Full Text] [Related]
3. A new delineation method research of the clinical target volume for pancreatic cancer adjuvant radiotherapy.
Zhang TT; Wei L; Yuan GW; Zhao DQ; Zhang ML; Zhang GF; Wang PC
Cancer Radiother; 2019 Jun; 23(3):201-208. PubMed ID: 31101540
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
Zhu X; Ju X; Cao Y; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):101-110. PubMed ID: 30684663
[TBL] [Abstract][Full Text] [Related]
5. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles.
Zhu X; Cao Y; Ju X; Zhao X; Jiang L; Ye Y; Shen Y; Cao F; Qing S; Zhang H
Cancer Sci; 2021 Jan; 112(1):287-295. PubMed ID: 32418280
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer.
Heerkens HD; Hall WA; Li XA; Knechtges P; Dalah E; Paulson ES; van den Berg CAT; Meijer GJ; Koay EJ; Crane CH; Aitken K; van Vulpen M; Erickson BA
Pract Radiat Oncol; 2017; 7(2):126-136. PubMed ID: 28089481
[TBL] [Abstract][Full Text] [Related]
8. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma.
Kim B; Kim YC; Noh OK; Heo J; Lee HW; Kim JH; Lee JH; Kim JK; Cho O; Oh YT; Chun M
Br J Radiol; 2017 Aug; 90(1077):20170225. PubMed ID: 28707545
[TBL] [Abstract][Full Text] [Related]
10. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC
Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.
Horowitz DP; Hsu CC; Wang J; Makary MA; Winter JM; Robinson R; Schulick RD; Cameron JL; Pawlik TM; Herman JM
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1391-7. PubMed ID: 20643511
[TBL] [Abstract][Full Text] [Related]
13. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma.
van der Geld YG; van Triest B; Verbakel WF; van Sörnsen de Koste JR; Senan S; Slotman BJ; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1215-20. PubMed ID: 18954715
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.
Lee SW; Fraass BA; Marsh LH; Herbort K; Gebarski SS; Martel MK; Radany EH; Lichter AS; Sandler HM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):79-88. PubMed ID: 9989517
[TBL] [Abstract][Full Text] [Related]
16. Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.
Katz MH; Wang H; Balachandran A; Bhosale P; Crane CH; Wang X; Pisters PW; Lee JE; Vauthey JN; Abdalla EK; Wolff R; Abbruzzese J; Varadhachary G; Chopin-Laly X; Charnsangavej C; Fleming JB
J Gastrointest Surg; 2012 Jan; 16(1):68-78; discussion 78-9. PubMed ID: 22065318
[TBL] [Abstract][Full Text] [Related]
17. Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.
Qiu H; Wild AT; Wang H; Fishman EK; Hruban RH; Laheru DA; Kumar R; Hacker-Prietz A; Tuli R; Tryggestad E; Schulick RD; Cameron JL; Edil BH; Pawlik TM; Wolfgang CL; Herman JM
Radiother Oncol; 2012 Aug; 104(2):167-72. PubMed ID: 22883106
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
19. Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy.
Zhang Y; Frampton AE; Kyriakides C; Bong JJ; Habib N; Ahmad R; Jiao LR
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1063-71. PubMed ID: 22392075
[TBL] [Abstract][Full Text] [Related]
20. Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.
Comito T; Cozzi L; Zerbi A; Franzese C; Clerici E; Tozzi A; Iftode C; Navarria P; D'Agostino G; Fogliata A; Mancosu P; Tomatis S; Carnaghi C; Personeni N; Santoro A; Scorsetti M
Eur J Surg Oncol; 2017 Apr; 43(4):735-742. PubMed ID: 28131670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
